跳至主要内容
临床试验/DRKS00004312
DRKS00004312已完成2 期

Efficacy of gencydo nasal spray on early nasal response after allergen exposition in patients with grass pollen allergy, a randomized, placebo controlled cross over study

iversitätsklinikum Freiburg, Leitender ärztlicher Direktor0 个研究点目标入组 41 人开始时间: 2012年10月29日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
41

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 50 Years(—)
性别
All

入选标准

  • men and women aged between 18 - 50 years
  • -symptoms of grass polen allergy for at least 2 years (sneezing, itching of nose, running nose, tears)
  • -proof of allergy through prick test
  • -signed consent

排除标准

  • Chronic serious illness (i.e. diabetes mellitus type I, chronic polyarthritis, tumors, heart insufficiency, HIV-Infection)
  • Asthma bronchiale with continuous therapy with inhalative or systemic steroides
  • Hypersensitivity against compounds of Gencydo (quince, lemon)
  • Treatment with Gencydo Nasal Spray within the last month before inclusion into the study
  • Therapy with antihistamines, Cromoglycine acid, steroides or other antiallergic medication with 2 weeks before inclusion into the study
  • anamnestic alcohol abuse >30g/d or iv. drug abuse
  • pregnancy or breat feeding
  • simultaneous participation in another clinical study within 3 months before inclusion into the study
  • acute infection of airways or allergic reaction with distant symptoms

研究者

发起方
iversitätsklinikum Freiburg, Leitender ärztlicher Direktor

相似试验

Efficacy of gencydo nasal spray on early nasal... | 临床试验